OneSource Specialty Pharma Limited (BOM:544292)
1,613.15
+5.75 (0.36%)
At close: Jun 22, 2026
BOM:544292 Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, BOM:544292 stock has a consensus rating of "Buy" and an average price target of ₹2,037. The average 1-year stock price forecast is 26.26% higher than the current stock price, while the lowest is ₹1,699 (+5.32%) and the highest is ₹2,300 (+42.58%).
Price Target: ₹2,037 (+26.26%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for BOM:544292 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Financial Forecast
Revenue This Year
22.30B
from 14.22B
Increased by 56.89%
Revenue Next Year
33.91B
from 22.30B
Increased by 52.05%
EPS This Year
41.20
from -5.74
EPS Next Year
81.00
from 41.20
Increased by 96.60%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.
Revenue Forecast
| Revenue | 2027 | 2028 |
|---|---|---|
| High | 24.7B | |
| Avg | 22.3B | |
| Low | 20.7B |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | 74.0% | |
| Avg | 56.9% | |
| Low | 45.6% |
EPS Forecast
| EPS | 2027 | 2028 |
|---|---|---|
| High | - | |
| Avg | 41.20 | |
| Low | - |
EPS Growth
| EPS Growth | 2027 | 2028 |
|---|---|---|
| High | - | |
| Avg | - | |
| Low | - |